The one thing the quarterly showed was Phase 1 Trial didn't begin until October, not in April as shown in clinical trials, or from the information that the IRB review was completed, which to me indicated the trial could start. Why it didn't start earlier wasn't explained, but their are many reasons for trials taking substantial time to get underway.

I only skimmed the release, but didn't find anything on the other trials indicated in the timeline, or to what Mediq may be doing. If others have spotted other information, please let us know.

It was nice to have a quarterly issued on schedule, perhaps the next time they do one they'll accompany it with a webcast to discuss it, like so many other companies do.

All and all, I believe we know a lot more about the company from what's happened in the last couple days, and I see nothing to be discouraged about.

Gary